与酒精相关的肝病中的酒精使用障碍的治疗:元分析
Ashwani K Singal1,2,3,4, Wanyu Zhang1, Akshay Shetty5
1Division of Gastroenterology Hepatology Nutrition, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Hepatology communications
|April 30, 2025
概括
酒精使用障碍治疗显著改善了与酒精相关的肝病患者的戒酒和肝脏结果. 需要进一步的研究来证实特定药物和综合多学科护理的好处.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 成 药物 药物 药物 药物
- 临床研究 临床研究
背景情况:
- 与酒精相关的肝病 (ALD) 是一个严重的健康问题.
- 酒精使用障碍 (AUD) 是ALD患者常见的并发症.
- 了解AUD治疗对ALD结果的影响至关重要.
研究的目的:
- 评估酒精使用障碍 (AUD) 治疗在酒精相关性肝病 (ALD) 患者中的有效性.
- 评估AUD治疗对酒精复发和肝脏相关结果的影响.
- 分析肝移植 (LT) 外部和内部的结果.
主要方法:
- 对25项符合条件的研究进行了系统审查和元分析.
- 包括93899名ALD患者 (33834人接受AUD干预).
- 随机对照试验 (RCT) 和观察性研究的分析.
主要成果:
- 在LT环境之外,AUD治疗减少了73%的酒精复发 (7项RCT) 和LT后的59% (8项观察性研究).
- 基于药物的AUD治疗显示,酒精复发率降低了77% (5项RCT).
- 观察性研究表明,再入院减少 (48%) 和减补偿 (52%),但非LT外的死亡率没有降低;在LT后,观察性研究中死亡率降低了56%.
结论:
- 在ALD患者中,AUD治疗明显改善了禁欲和肝脏相关的结果,无论LT状态如何.
- 需要进一步的RCT来研究特定AUD药物的疗效,以及针对双重AUD和肝脏疾病病理学的综合多学科治疗方法.
相关概念视频
Enzyme Inhibition
77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K
CNS Depressants: Alcohol and Nicotine
151
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
151
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128


